Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
Vélez ID. et al, (2021), Lancet Child Adolesc Health
Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection
Mukaka M. et al, (2021), Malaria Journal, 20
Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination
Jacob CG. et al, (2021), eLife, 10
Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children.
Han AX. et al, (2021), eLife, 10
Taylor WR. et al, (2021)
MalariaGEN None. et al, (2021)
Ahouidi A. et al, (2021), Wellcome Open Research, 6, 42 - 42
Chau NVV. et al, (2021), Emerging infectious diseases, 27
The Natural History and Transmission Potential of Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Van Vinh Chau N. et al, (2020), Clinical Infectious Diseases, 71, 2679 - 2687
SARS-CoV-2 and co-infections detection in nasopharyngeal throat swabs of COVID-19 patients by metagenomics.
Van Tan L. et al, (2020), The Journal of infection, 81, e175 - e177
St Jean PL. et al, (2020), Pharmacogenetics and genomics
A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam
Kestelyn E. et al, (2020), Wellcome Open Research, 5, 141 - 141
Detecting geospatial patterns of Plasmodium falciparum parasite migration in Cambodia using optimized estimated effective migration surfaces.
Li Y. et al, (2020), International journal of health geographics, 19
Phu NH. et al, (2020), Clinical Infectious Diseases
Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials
Phommasone K. et al, (2020), PLOS ONE, 15, e0228190 - e0228190
A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam.
Kestelyn E. et al, (2020), Wellcome open research, 5
Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam.
Nguyen TT. et al, (2020), PloS one, 15
Hien TT. et al, (2020), Journal of Engineering and Technological Sciences, 52, 208 - 221
Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.
Malaria Genomic Epidemiology Network None., (2019), Nature communications, 10